Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: New York
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Generic Pharma

ACT:US

296.1401 USD 0.0899 0.03%

As of 18:40:03 ET on 03/04/2015.

Company Profile for Actavis plc (ACT)

Actavis plc manufactures specialty pharmaceuticals. The Company develops, manufactures and distributes generic, brand and over-the-counter products. Actavis offers its pharmaceutical drugs around the world.

Contact Information

Actavis plc

Morris Corporate Center III
400 Interpace Parkway
Parsippany, NJ 07054
United States
Phone: 1-862-261-7000

Key Executives for Actavis plc (ACT)

Paul M BisaroChairmanBrenton L Saunders "Brent"President/CEO
Maria Teresa Hilado "Tessa"Chief Financial OfficerRobert A Stewart "Bob"Chief Operating Officer
Karen LingChief Human Resources OfficerJames C D'AreccaChief Accounting Officer
Charles M MayrChief Communications Ofcr:GlobalA Robert Bailey "Bob"Chief Legal Officer/Secretary
William Meury "Bill"Exec VP:CommercialDavid A BuchenExec VP:Commercial
Lisa M DefrancescoVP:Global Investor Relations

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil